United States Veterinary Healthcare Market - Growth, Trends, and Forecast (2019 - 2024)

The market is segmented by Product (Therapeutics and Diagnostics), and Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animals).

Market Snapshot

United States Veterinary Healthcare market Image 1
Study Period:


Base Year:




Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The United States is among the major regions across the world which highly supports the healthcare of veterainary animals both in companion animals (e.g. dogs, cats, and horses) and production (e.g. cattle, pigs, sheep, poultry  etc.) animal species categories. A large population investing in pet insurance, across the developed markets, is driving growth in the market being studied. As per the American Pet Production Association’s (APPA) National pet owners survey, 2017-2018 reports, the United States is home to 89.7 million dogs; 94.2 million cats; and 7.6 million horses. Moreover, 68% of US households own pets, which is equal to 84.6 million homes, out of which 60.2 million households own dogs, 47.1 million houses own cats, and 2.6 million houses own horse. With rising number of owners, there is growing demand for routine veterinary services which majorly drives the demand of vertinary healthcare market in the United States.

Scope of the Report

As per the scope of this report, the veterinary healthcare market comprising therapeutic products and solutions for companion and farm animals. Companion animals can be tamed or adopted for companionship or as house/office guards, and farm animals are raised for meat and milk-related products. Companion animals include canine, feline, and equine. Farm animals are bovine, poultry, and porcine.

By Product
By Therapeutics
Medical Feed Additives
Other Therapeutics
By Diagnostics
Immunodiagnostic Tests
Molecular Diagnostics
Diagnostic Imaging
Clinical Chemistry
Other Diagnostics
By Animal Type
Dogs and Cats
Other Animals

Report scope can be customized per your requirements. Click here.

Key Market Trends

Medical Feed Additives Estimated to Obtain Fast Growth Rate, Over the Forecast Period

Medicinal feed additives are important ingredients added to an animal diet, to treat diseases and improve nutrition. It is a stress-free and safe manner in administering veterinary medicines and is as effective as other administrative routes, such as injection, in-water, and tablets. The production, supply, and use of medicinal feed additives are highly well-regulated at all the stages, by the United States. Recently in 2019, Trouw Nutrition, subsidiary of Nutreco, collaborated with Bayer Animal Health GmbH to drive the development of novel technologies and applications for the animal health and animal nutrition industries, with additional focus on medical feed additives. Such activities drive the demand and usage of products for animals healthcare.

United States Veterinary Healthcare market Image 2

To understand key trends, Download Sample Report

Competitive Landscape

The major market players are focusing imporved diagnostics technqies for animal care, specially protecting the aniamls from diseases from changing weather conditions. Some of the major players in the market are Boehringer Ingelheim International GmbH, Eli Lilly and Company (Elanco Animal Health), Merck & Co. Inc., Zoetis, Inc, and Sanofi Merial, among others.

Major Players

  1. Boehringer Ingelheim International GmbH
  2. Eli Lilly and Company (Elanco Animal Health)
  3. Merck & Co. Inc.
  4. Zoetis, Inc
  5. Idexx Laboratories

* Complete list of players covered available in the table of contents below

United States Veterinary Healthcare market Image 3

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Advanced Technology Leading to Innovations in Animal Healthcare

      2. 4.2.2 Increasing Productivity at the Risk of Emerging Zoonosis

      3. 4.2.3 Increasing Initiatives by the Governments and Animal Welfare Associations

    3. 4.3 Market Restraints

      1. 4.3.1 High Costs Related to Animal Testing

      2. 4.3.2 Strict Regulations on Therapeutics

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 By Therapeutics

        1. Vaccines

        2. Parasiticides

        3. Anti-infectives

        4. Medical Feed Additives

        5. Other Therapeutics

      2. 5.1.2 By Diagnostics

        1. Immunodiagnostic Tests

        2. Molecular Diagnostics

        3. Diagnostic Imaging

        4. Clinical Chemistry

        5. Other Diagnostics

    2. 5.2 By Animal Type

      1. 5.2.1 Dogs and Cats

      2. 5.2.2 Horses

      3. 5.2.3 Ruminants

      4. 5.2.4 Swine

      5. 5.2.5 Poultry

      6. 5.2.6 Other Animals


    1. 6.1 Company Profiles

      1. 6.1.1 Boehringer Ingelheim International GmbH

      2. 6.1.2 Ceva Holdings Inc. (Ceva Animal Health Inc).

      3. 6.1.3 Eli Lilly and Company (Elanco Animal Health)

      4. 6.1.4 Idexx Laboratories

      5. 6.1.5 Merck & Co. Inc.

      6. 6.1.6 Novartis AG (Novartis Animal Health)

      7. 6.1.7 Randox Laboratories, Ltd

      8. 6.1.8 Virbac SA

      9. 6.1.9 Zoetis, Inc

      10. 6.1.10 List Not Exhaustive

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!

Complete your payment details below

Shipping & Billing Information

Payment Information